Cutaneous follicle center lymphoma, extranodal and solid organ sites
ICD-10 C82.69 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, extranodal and solid organ sites.
Cutaneous follicle center lymphoma (CFCL) is a subtype of non-Hodgkin lymphoma that primarily affects the skin and is characterized by the proliferation of follicle center (germinal center) B-cells. When CFCL presents in extranodal and solid organ sites, it indicates a more advanced stage of the disease, where the lymphoma has spread beyond the skin to other organs such as the liver, spleen, or lymph nodes. Patients may present with localized skin lesions, which can be nodular or plaque-like, and may experience systemic symptoms. The disease can be indolent or aggressive, and its clinical behavior can vary significantly. Staging is crucial for determining the extent of the disease and guiding treatment, which may include chemotherapy, radiation therapy, or targeted therapies. B-symptoms, such as fever, night sweats, and weight loss, may also be present and are indicative of a more systemic involvement of the lymphoma. Accurate diagnosis often requires a biopsy and histological examination to confirm the presence of follicle center cells.
Comprehensive documentation of diagnosis, staging, treatment plan, and follow-up.
Diagnosis of CFCL, treatment planning, and management of complications.
Ensure accurate staging and documentation of any systemic symptoms.
Detailed descriptions of skin lesions, biopsy results, and treatment responses.
Initial presentation of skin lesions, management of localized disease.
Document any changes in skin lesions and systemic symptoms.
Used to assess overall health and detect blood disorders in patients with CFCL.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure that all relevant lab results are included in the patient's record.
Common symptoms include skin lesions, which may be nodular or plaque-like, and systemic B-symptoms such as fever, night sweats, and weight loss.